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Abstract
Genetic alterations of the maternal UBE3A allele result in Angelman syndrome (AS), a
neurodevelopmental disorder characterized by severe developmental delay, lack of speech, and
difficulty with movement and balance. The combined effects of maternal UBE3A mutation and
cell type-specific epigenetic silencing of paternal UBE3A are hypothesized to result in a complete
loss of functional UBE3A protein in neurons. However, the allelic specificity of UBE3A
expression in neurons and other cell types in the brain has yet to be characterized throughout
development, including the early postnatal period when AS phenotypes emerge. Here we define
maternal and paternal allele-specific Ube3a protein expression throughout postnatal brain
development in the mouse, a species which exhibits orthologous epigenetic silencing of paternal
Ube3a in neurons and AS-like behavioral phenotypes subsequent to maternal Ube3a deletion. We
find that neurons downregulate paternal Ube3a protein expression as they mature and, with the
exception of neurons born from postnatal stem cell niches, do not express detectable paternal
Ube3a beyond the first postnatal week. By contrast, neurons express maternal Ube3a throughout
postnatal development, during which time localization of the protein becomes increasingly
nuclear. Unlike neurons, astrocytes and oligodendrotyes biallelically express Ube3a. Notably,
mature oligodendrocytes emerge as the predominant Ube3a-expressing glial cell type in the cortex
and white matter tracts during postnatal development. These findings demonstrate the
spatiotemporal characteristics of allele-specific Ube3a expression in key brain cell types, thereby
improving our understanding of the developmental parameters of paternal Ube3a silencing and the
cellular basis of AS.
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In 1965, Harry Angelman first described the neurodevelopmental disorder that is known
today as Angelman syndrome (AS) (Bower and Jeavons, 1967). AS is characterized by a
constellation of symptoms that emerge during early childhood, including developmental
delay, ataxia, lack of speech, paroxysmal laughter, seizures, and frequently comorbid autism
(Peters et al., 2004; Williams et al., 2006; Thibert et al., 2013). Large maternal deletions
(approximately 6 megabases) of the 15q11-q13 chromosomal region, which encompasses
UBE3A, are the most common genetic cause of AS (Williams et al., 2010). UBE3A encodes
a HECT (homologous to E6-associated protein carboxyl-terminus) domain E3 ubiquitin
ligase (Scheffner et al., 1993; Yamamoto et al., 1997), and is the only gene within the
15q11-q13 region whose expression is unequivocally maternally biased (Leung et al., 2011).
This bias is due to neuron-specific epigenetic silencing of the paternal UBE3A allele
(Albrecht et al., 1997; Yamasaki, 2003; Landers et al., 2004). Critical UBE3A function may
thus be completely lost in neurons when maternal UBE3A is compromised, and this may be
the proximal molecular cause of AS. Indeed, deletions or mutations of maternal UBE3A
alone are sufficient to result in an AS diagnosis, including those that selectively abrogate the
ubiquitin ligase functionality of UBE3A protein (Cooper et al., 2004). Co-occurring
haploinsufficiency of biallelically expressed genes in the 15q11-q13 region is thought to
enhance the severity of AS phenotypes in large deletion cases (Moncla et al., 1999; Lossie et
al., 2001; Gentile et al., 2010).
The hypothesis that maternal UBE3A loss in neurons is sufficient to cause AS, however
parsimonious, has yet to be directly tested. In fact, relatively little is known about allelic
contributions to UBE3A protein expression in neurons and glia during brain development.
Three overarching questions remain to be answered: 1) Is paternal UBE3A completely
silenced in neurons and, if so, by what developmental time point? 2) Which glial cells in the
brain express UBE3A? 3) What are the allelic contributions to glial UBE3A expression? The
mouse is a suitable model species in which to address these questions; the orthologous
mouse Ube3a gene resides within a chromosomal region that is syntenic with human 15q11-
q13 and is subject to paternal epigenetic silencing in neurons (Nicholls and Knepper, 2001).
Moreover, mice lacking a functional copy of maternal Ube3a (AS mice) exhibit AS-like
phenotypes (Jiang et al., 1998; Miura et al., 2002). Some AS-relevant phenotypes are more
severe in Ube3a double knock-out mice than in AS mice (Jiang et al., 1998; Heck et al.,
2008). This suggests that paternal Ube3a expression also contributes to brain development
and function, though paternal Ube3a deletion per se does not cause AS-like phenotypes
(Jiang et al., 1998; Miura et al., 2002; Heck et al., 2008; Mulherkar and Jana, 2010). It is
possible that immature neurons express and require paternal Ube3a expression during early
postnatal development (Leung et al., 2009; Sato and Stryker, 2010). Consequently, neuronal
function may be maximally impaired in Ube3a double knock-out mice. Glial cells are
presumed to biallelically express Ube3a, regardless of their maturational status (Yamasaki,
2003). Glia may also require two functional Ube3a alleles for optimal development and
function.
In the present study we took advantage of preexisting mouse models and complementary
immunohistochemical approaches to reliably and extensively track allele-specific Ube3a
protein expression. As a result, we further resolved the developmental dynamics of maternal
and paternal Ube3a protein expression in neurons and glia and, in turn, improved our
understanding of how maternal UBE3A loss might contribute to AS pathogenesis.
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Breeding and genotyping mice
Ube3a knock-out mice were generated by the laboratory of A. Beaudet (Jiang et al., 1998)
and backcrossed to a congenic C57BL/6J background by Y. Jiang. Angelman syndrome
(AS) model mice (Ube3am–/p+) maternally inherit the Ube3a knock-out allele and were
typically generated by mating wild-type (Ube3am+/p+) male mice to female mice with
paternal inheritance of the Ube3a knock-out allele (Ube3am+/p–). Female Ube3am+/p– mice
were mated to male Ube3am+/p– mice to produce litters comprised of Ube3am+/p+,
Ube3am+p/–, Ube3am–/p+, and double knock-out (Ube3am–/p–) offspring. Ube3a knock-out
mice were genotyped via polymerase chain reaction (PCR). PCR primers used to amplify
the wild-type Ube3a allele were: Ube3a Forward 5’-TGAGTTTCCCCTGATGGAAG -3’
and Ube3a Reverse 5’-GGAAATTCACTACTACCTCCCAAA -3’. Primers used to amplify
the Ube3a knock-out allele were: Neomycin Forward 5’-
AGACAATCGGCTGCTCTGAT-3’ and Neomycin Reverse 5’-
ATACTTTCTCGGCAGGAGCA -3’.
Knock-in mice expressing yellow fluorescent protein (YFP) fused to the carboxyl-terminus
of Ube3a were generated and generously provided by the laboratory of A. Beaudet (Dindot
et al., 2008) and were maintained on a congenic C57BL/6J background. Mice with maternal
Ube3a-YFP inheritance (Ube3amYFP/p+) were generated by mating wild-type males to
paternal Ube3a-YFP (Ube3am+/pYFP) females. The reciprocal mating scheme was used to
generate Ube3am+/pYFP offspring. EGFP Forward 5’-CACATGAAGCAGCACGACTT-‘3
and EGFP Reverse 5’-AGTTCACCTTGATGCCGTTC-‘3 genotyping primers were used to
amplify the Ube3a-YFP knock-in allele.
A cross-sectional approach was employed to assess allele-specific expression patterns of
endogenous Ube3a and Ube3a-YFP throughout postnatal development. For each genetic
cross of interest, brains from at least 3 sets of littermates and from at least two independent
litters were analyzed. All research procedures using mice were approved by the Institutional
Animal Care and Use Committee at the University of North Carolina, Chapel Hill and
conformed to NIH guidelines.
Histology and immunostaining
Postnatal mice were deeply anesthetized with sodium pentobarbital (60 mg/kg i.p.) prior to
transcardial perfusion with room temperature phosphate-buffered saline (PBS) immediately
followed by room temperature phosphate-buffered 4% paraformaldehyde (pH 7.3). Perfused
brains were removed from their skulls and post-fixed overnight at 4°C prior to being
cryoprotected via sequential 12-hour incubations in 10%, 20%, and 30% sucrose in PBS (pH
7.5). Cryoprotected brains were frozen on dry ice and cut into 40 μm-thick sections with a
sliding microtome (Thermo Scientific, Kalamazoo, MI, USA). Sections were stored in a
cryopreservative solution (by volume: 45% PBS, 30% ethylene glycol, 25% glycerol) at
−20°C until they were processed for free-floating immunohistochemistry.
For chromogenic staining, sections were rinsed several times in Tris-buffered saline
containing 0.3% Triton-X-100 (TBST) prior to antigen retrieval with 10 mM Na Citrate pH
6.0 with 0.05% Triton-X-100 (heated to 75°C for 20 minutes). Additional rinsing in TBST
preceded two blocking steps. First, sections were incubated for 5 minutes in H2O2 (0.3% in
MeOH) to quench endogenous peroxidases, followed by TBST rinsing. Second, sections
were blocked in 4% nonfat milk in TBST (Blotto) for 25 minutes at room temperature.
Blocked tissue sections were incubated in primary antibodies diluted in Blotto for 48-72
hours at 4°C. After incubation in primary antibodies, sections were rinsed several times in
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Blotto before incubation for 2 hours at room temperature with biotinylated donkey anti-
mouse secondary antibodies (Jackson Immunoresearch, West Grove, PA, 715-066-150)
diluted 1:1,000 in Blotto. Sections were then rinsed in TBST prior to tertiary amplification
with the ABC elite avidin-biotin-peroxidase system (Vector Labs, Burlingame, CA, USA).
Further rinsing in TBST preceded a 10 minute incubation at room temperature in 3’3’-
diaminobenzidine (DAB) chromogenic substrate (0.02% DAB and 0.01% H2O2 in TBST) to
visualize immune complexes amplified by avidin-biotin-peroxidase.
For immunofluorescent staining, sections were rinsed several times in PBS before blocking
in PBS plus 5% normal goat serum and 0.2% Triton-X-100 (NGST) for 1 hour at room
temperature. Blocked tissue sections were incubated in primary antibodies diluted in NGST
for 48 hours at 4°C. Sections were then rinsed several times in PBS containing 0.2% Triton-
X-100 (PBST) before incubation in secondary antibodies (also diluted in NGST) for 1 hour
at room temperature. The following secondary antibodies from Invitrogen (Carlsbad, CA,
USA) were used at a 1:500 dilution: goat anti-mouse Alexa 633 (A21052); goat anti-rabbit
Alexa 568 (A11011); goat anti-chicken Alexa 488 (A11039); goat anti-rabbit Alexa 633
(A21052); goat anti-mouse IgG1 Alexa 568 (A21124); goat anti-mouse IgG2a Alexa 488
(A21131). In most experiments, 4',6-diamidino-2-phenylindole (DAPI, Invitrogen D1306)
was added during the secondary antibody incubation at a concentration of 700 ng/mL for
nuclear counterstaining. Brain sections compared within figures were stained within the
same experiment, under identical conditions.
Western Blotting
Mice were deeply anesthetized with sodium pentobarbital (60 mg/kg i.p.) prior to
decapitation and brain removal. The neocortical hemispheres and hippocampi from each
harvested brain were rapidly dissected in ice-cold PBS and then immediately snap-frozen
with liquid nitrogen and stored at −80°C. Frozen tissue samples were homogenized in a
glass tissue homogenizer (Wheaton, Millville, NJ, USA) with ice-cold RIPA buffer (50 mM
Tris pH 8.0, 150 mM NaCl, 1% triton x-100, 0.1% SDS, 0.5% Na Deoxycholate)
supplemented with 2 mM EDTA and a protease inhibitor cocktail (Sigma, Saint Louis, MO,
USA). Tissue homogenates were cleared by 16,000 × g centrifugation for 20 minutes at 4°C
and protein concentrations of the supernatants were determined using the BCA assay
(Thermo Scientific). Protein samples (30 μg per lane) were resolved by SDS-PAGE and
transferred to nitrocellulose membranes. Membranes were blocked for 1 hour at room
temperature in Odyssey blocking buffer (Li-COR, Lincoln, NE, USA) prior to incubation
overnight at 4°C with primary antibodies diluted in a 1:1 solution of blocking buffer and
Tris-buffered saline containing 0.1% Tween-20 (TBSTween). Membranes were
subsequently washed repeatedly with TBSTween prior to incubation for 1 hour at room
temperature with secondary antibodies prepared in the same diluent as the primary
antibodies. The following secondary antibodies were used: 1:10,000 donkey anti-mouse
800CW (LI-COR, 926-32212); 1:5,000 donkey anti-rabbit Alexa 680 (Invitrogen, A10043).
Finally, blots were washed repeatedly in TBSTween followed by TBS alone prior to
imaging with the Odyssey imaging system (LI-COR).
Antibody characterization
The list of employed primary antibodies is provided in Table 1. APC antibody weakly
stained astrocytes and immature oligodendrocytes and intensely stained mature
oligodendrocytes in white matter tracts and in deep layers of the cerebral cortex, consistent
with manufacturer's specifications and previous reports (Dimou et al., 2008).
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Cplx3 antibody does not stain brain tissue from Cplx3–/– mice (Reim et al., 2009). In our
hands this antibody specifically stained a subpopulation of subplate neurons in the cerebral
cortex, as predicted by a previous study (Hoerder-Suabedissen and Molnar, 2013).
DARPP-32 antibody recognizes a single band of 32 kD on Western blots of rat brain lysate
(manufacturer's specifications). We observed this antibody to specifically stain patches of
cells in the early postnatal brain that co-localized with tyrosine-hydroxylase-stained axon
terminals (data not shown).
GAPDH antibody recognized a single band of approximately 37 kDa in Western blotting
experiments, consistent with previous experiments (Jones et al., 2008).
GFAP antibody was previously shown to exhibit a lack of staining in GFAP–/– brain tissue
(Hanbury et al., 2003). We observed this antibody to exclusively stain NeuN-negative cells
with characteristic astrocytic morphologies throughout the brain.
GFP antibody was previously shown to stain only brain cells in mice that express transgenic
GFP (Xu et al., 2006). We observed GFP antibody to produce staining patterns in Ube3a-
YFP knockin mice that were nearly identical to endogenous Ube3a expression patterns. We
observed no staining in wild type mice using this antibody.
Ki67 antibody has been shown repeatedly to co-localize with short-pulse BrdU-labeled
proliferating cells (Mathews et al., 2010; Tseng et al., 2010). We found this antibody to stain
sparse populations of Nestin-positive cells in known proliferative niches of the postnatal
brain.
Olig2 antibody specifically labels cells of the oligodendrocyte lineage (Tripathi and
McTigue, 2008), consistent with our own observations.
Nestin antibody was previously shown to specifically stain neural precursors (Kao et al.,
2008). Consistent with this observation, we found that this antibody specifically stains cells
in the adult subventricular zone and subgranular zone of the dentate gyrus in postnatal mice
in which proliferating, Ki67-positive cells were also prominently localized.
NeuN antibody stains only neuronal perikarya and nuclei (Encinas et al., 2011). We
consistently observed this antibody to stain neuronal populations and never observed this
antibody to co-localize with glial markers.
Ube3a antibodies used in this study consistently showed drastically reduced
immunoreactivity in Ube3am–/p+ brain tissue samples and a complete lack of
immunoreactivity in Ube3am–/p– brain tissue samples.
Imaging and figure production
Images of brain sections stained with DAB histochemistry were acquired with a Nikon
Eclipse 80i microscope (Nikon, Melville, NY, USA) equipped with Surveyor mosaic
imaging software (Objective Imaging Ltd., Cambridge, United Kingdom). Images of brain
sections stained using fluorophore-conjugated secondary antibodies were acquired with a
Zeiss LSM 710 confocal microscope equipped with ZEN imaging Software (Zeiss, Jena,
Germany). Images compared within figures were taken within the same imaging session
using identical acquisition parameters. Occasionally, images within figure panels were
linearly adjusted for brightness and contrast using Image J software (Schneider et al., 2012).
All images to be compared underwent identical manipulations with the exception that the
relative brightness of the Ube3a signal for some Ube3am–/p– images had to be enhanced so
that low levels of non-specific background staining could be appreciated. This was due to
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the large dynamic range of the signal and our preference to avoid saturating the Ube3a
signal in Ube3am+/p+ samples during imaging. These instances are clearly noted in the
figure legends. Figures were prepared using Adobe Illustrator software (Adobe Systems
Inc., San Jose, CA, USA).
RESULTS
To begin mapping allele-specific patterns of Ube3a expression in the developing postnatal
brain, we utilized an immunohistochemical protocol that was previously shown to
specifically stain Ube3a protein in the adult brain (Gustin et al., 2010). We applied this
protocol to brain sections from wild-type (Ube3am+/p+) mice across postnatal development
and, in general, we observed a broad distribution of staining (Fig. 1A). Upon closer
inspection, we saw discrete patterns of Ube3a staining within the deepest laminae of the
neocortex and in patches of cells in the striatum during the first postnatal week (Fig. 1C, D,
M, N). These patterns were less apparent by the end of the second postnatal week (Fig. 1E,
O), as staining in adjacent layers (neocortex) or surrounding cells (striatum) became
equivalent. A broad, relatively uniform distribution of Ube3a staining persisted into
adulthood (Fig. 1F, G, P, Q).
In parallel, we stained brain sections from littermate AS model mice (Ube3am–/p+ mice).
The Ube3a null allele produces neither transcript nor protein (Jiang et al., 1998);
consequently, any staining in Ube3am–/p+ mice is likely owed to the presence of protein
generated from the paternal Ube3a allele. We did not detect paternal Ube3a staining at any
of the postnatal time points we examined (Fig. 1B, H-L, R-V). This was somewhat
surprising considering that paternal Ube3a constitutes about 5% of total Ube3a protein as
demonstrated by comparative Western analysis of Ube3am+/p+ and Ube3am–/p+ brain lysates
(Gustin et al., 2010).
We considered insufficient assay sensitivity to be the most likely explanation for our failure
to detect paternal Ube3a staining with this previously published protocol. Therefore, we
developed an immunofluorescent Ube3a staining protocol with the goal of detecting low
levels of sparsely distributed paternal Ube3a protein. With low magnification, we observed
gross patterns of Ube3a staining across development that were nearly identical to what we
previously observed; Ube3a was broadly distributed throughout the Ube3am+/p+ brain yet
most notable in deep cortical laminae and patches of striatal cells during the first postnatal
week (Fig. 2A-C). Staining was grossly absent in age-matched Ube3am–/p+ brain sections
(Fig. 2D-F), save for an intriguing pattern of signal in the superficial neocortex of perinatal
mice (Fig. 2D). However, with increased magnification we were able to detect paternal
Ube3a staining at all postnatal ages in small cells resembling glia (Fig. 2J-L), a staining
pattern which was absent in Ube3am–/p– brain sections (Fig. 2G-I, M-O). These results
indicated that our immunofluorescent Ube3a staining protocol was sensitive enough to
detect very low levels of paternal Ube3a in the brain. We implemented this new protocol in
a series of co-immunostaining studies designed to characterize the spatiotemporal dynamics
of maternal and paternal Ube3a protein expression during postnatal brain development (see
below).
Dynamic patterns of allele-specific Ube3a expression reflect neuronal maturation in the
postnatal brain
Cytoplasmic versus nuclear expression of maternal Ube3a shifts during
neuronal maturation—Ube3a staining was most salient in deep neocortical laminae and
in patches of striatal cells in the early postnatal brain (Figs. 1A, B and 2A, B). These notable
patterns were absent in Ube3am–/p+ mice (Figs. 1F, G and 2D, E), indicating that they were
solely the product of expression from the maternal Ube3a allele. Patchy maternal Ube3a
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staining in the striatum was highly reminiscent of the anatomical compartments referred to
as striosomes, which can be distinguished from surrounding matrix compartments by
predominantly limbic-related afferent inputs (Gerfen, 1989; Eblen and Graybiel, 1995) as
well as the expression of distinct neurochemical markers such as the dopamine- and cAMP-
regulated phosphoprotein of 32 kilodaltons (DARPP-32) (Foster et al., 1987). We found
patches of maternal Ube3a staining that co-localized perfectly with patches of DARPP-32
staining at postnatal day (P) 0 (Fig. 3A-D) up until P7 (Fig. 3E-H) when the pattern became
somewhat less salient. The most salient maternal Ube3a staining in the perinatal neocortex
was restricted to a thin band of cells immediately adjacent to the subcortical white matter.
We correctly assumed that these were residual neurons of the transient subplate layer as
evidenced by co-staining with Complexin3 (Cplx3) (Fig. 3I-L), a known marker of
surviving subplate neurons in the postnatal cortex (Hoerder-Suabedissen and Molnar, 2013).
This co-localization pattern was still apparent at P7 (Fig. 3M-P), although we also detected
maternal Ube3a-positive neuronal nuclei throughout the infragranular neocortical layers at
this time point.
Subplate and striosomal neurons are among the earliest-born neurons in the neocortex
(Kostovic and Rakic, 1980; Chun and Shatz, 1989; Price et al., 1997) and striatum (Fishell
and van der Kooy, 1987; van der Kooy and Fishell, 1987), respectively. Therefore, the
precocious salience of maternal Ube3a staining in these neurons may reflect their advanced
maturation relative to later-born neurons overlying or surrounding them. To address this
possibility, we evaluated changes in nuclear Ube3a staining in the context of laminar
gradients of neocortical maturation, since nuclear localization is a key factor contributing to
the salience of the maternal Ube3a stain. We found that a prominent nuclear distribution of
maternal Ube3a staining was nearly exclusive to subplate neurons at P0 (Fig. 4A). By P7,
neurons throughout infragranular neocortex exhibited prominent nuclear Ube3a staining,
whereas staining in overlying superficial layers was still largely cytoplasmic (Fig. 4B).
Prominent nuclear maternal Ube3a staining appeared latest in neurons of the most
superficial layers (Fig. 4C) in accordance with a deep to superficial (“inside-out”) gradient
of cortical development (Angevine and Sidman, 1961; Rakic, 1974). Furthermore, we
detected a profound cytoplasmic to nuclear shift in the distribution of maternal Ube3a
staining within neocortical layers during development (Fig. 4D-L). Collectively, these
findings suggested that the subcellular localization of maternal Ube3a becomes increasingly
nuclear as neurons mature.
Paternal Ube3a expression in neurons is exclusive to immature cells—Only a
few paternal Ube3a staining patterns were conspicuous in the brains of Ube3am–/p+ mice.
One particularly remarkable pattern was a deep (low) to superficial (high) gradient in the P0
neocortex (Figs. 2D and 5A). Superficial neocortical neurons are later-born and less mature
than their underlying counterparts. Accordingly, the staining gradient for NeuN, a mature
neuron marker, was reciprocal to the paternal Ube3a staining gradient (Fig. 5B-D). Neurons
beyond the superficial extent of the NeuN gradient stained most intensely for paternal Ube3a
(Fig. 5E-G). By P7, we could no longer detect paternal Ube3a staining in neurons, and we
observed an overall increase in the intensity of the NeuN staining, which was uniformly
distributed across layers (Fig. 5H-N). Western blotting of P0 and P7 lysates confirmed the
developmental downregulation of paternal Ube3a expression in the Ube3am–/p+ neocortex
and hippocampus as neurons mature during the first postnatal week (Fig. 5O).
We wondered if other populations of immature neurons might preferentially stain for
paternal Ube3a. We focused on granule cells in the dentate gyrus and the cerebellum, whose
generation and maturation is ongoing in the early postnatal brain (Altman and Das, 1966;
Bayer and Altman, 1975). At P7, paternal Ube3a staining was clearly enriched in the dentate
gyrus, especially in deeper granule cell layers adjacent to the hilus (Fig. 6A) and in the
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cerebellum, preferentially deep within the external granule cell layer (Fig. 6H). We further
analyzed patterns of paternal Ube3a and NeuN co-localization within these structures. We
observed a clear deep (high) to superficial (low or absent) gradient of paternal Ube3a
staining across the dentate granule cell layers (Fig. 6B, E), and this gradient was reciprocal
to that of NeuN (Fig. 6C, D, F, G). The relationship between paternal Ube3a and NeuN
expression was reminiscent of what we observed in the perinatal cortex (Fig. 5A-G).
Moreover, the staining pattern was consistent with the established superficial to deep
(“outside-in”) gradient of neuronal maturation across layers (Schlessinger et al., 1975;
Mathews et al., 2010). Ube3a staining in the early postnatal cerebellum was most salient
within the inner margin of the external granule cell layer, wherein newly generated neurons
are beginning a radial phase of migration toward their final position in the internal granule
cell layer (Fig. 6I, L) (Komuro and Rakic, 1998). These cells were weakly NeuN-positive
prior to and during radial migration (Fig. 6J, K, M, N), reflecting their immature status.
Taken together, these findings suggested that paternal Ube3a protein expression is a
generalizable feature of immature neurons in the developing brain.
Postnatal neural stem cells biallelically express Ube3a
Immature neurons express paternal Ube3a. This led us to question whether neural progenitor
cells might also express this protein. We addressed this question by co-immunostaining for
Ube3a and two markers of proliferating, self-renewable neural stem cells – Nestin and Ki67.
We observed a pattern of paternal Ube3a staining in P28 Ube3am–/p+ mice which resembled
the subgranular zone (SGZ) of the dentate gyrus – the site of postnatal hippocampal
neurogenesis (Fig. 7B). Paternal Ube3a-stained cells within this region co-stained
extensively with Nestin (Fig. 7D, E, G, I) and restrictively with Ki67 (Fig. 7D, F, H, I).
Because such staining patterns were absent in Ube3am–/p– mice (Fig. 7C), we were confident
in the specificity of paternal Ube3a staining in these neural stem cells. Ube3a staining in the
SGZ was much more difficult to appreciate in Ube3am+/p+ mice due to the overwhelming
intensity of maternal Ube3a staining in surrounding neurons (Fig. 7A).
To determine if SGZ neural stem cells biallelically express Ube3a, we performed similar
immunostaining experiments in Ube3a-YFP fusion protein knock-in mice, which facilitate
the tracking of allele-specific Ube3a protein expression (Dindot et al., 2008). By
immunostaining with GFP antibodies, which also recognize YFP, we were able to detect an
SGZ-like pattern of maternal Ube3a-YFP expression in the dentate gyrus of maternal
Ube3a-YFP (Ube3amYFP/p+) mice (Fig. 7J). Notably, this pattern was not obscured as it was
with Ube3a staining in Ube3am+/p+ mice (Fig. 7A), perhaps owing to relatively decreased
expression or stability of the maternal Ube3a-YFP protein in neurons. Paternal Ube3a-YFP
staining in Ube3am+/pYFP mice also yielded an SGZ-like pattern (Fig. 7K), which was
strikingly similar to the paternal Ube3a staining pattern observed in the Ube3am–/p+ dentate
gyrus (Fig. 7B). Importantly, we did not detect Ube3a-YFP staining in the dentate gyrus of
Ube3am+/p+ mice (Fig. 7L), confirming the specificity of the staining patterns that we
observed. Both maternal (Fig. 7M-R) and paternal (Fig. 7S-X) Ube3a-YFP-stained cells
within the SGZ proved to be Nestin and Ki67 co-positive, fully supporting that SGZ neural
stem cells biallelically express Ube3a. From these same co-immunostaining experiments, we
also determined that neural stem cells of the postnatal subventricular zone express both
maternal and paternal Ube3a-YFP (data not shown). Therefore, neural progenitors within
major postnatal neural stem cell niches appear to biallelically express Ube3a.
Oligodendrocytes and astrocytes biallelically express Ube3a
Olig2-expressing glia biallelically express Ube3a during neocortical
gliogenesis—We observed paternal Ube3a staining of glia throughout the neocortex and
underlying white matter of Ube3am–/p+ mice at P7 (Figs. 5I-N and 8C), the peak of
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neocortical gliogenesis (Bandeira et al., 2009). We also detected Ube3a-stained glial profiles
among stained axons in the white matter of Ube3am+/p+ mice (Fig. 8B, D), though glial
staining in the overlying grey matter was obscured by maternal Ube3a staining in neurons.
The vast majority of Ube3a-stained glia in Ube3am+/p+ (Fig. 8D, E, G, I) and Ube3am–/p+
mice (Fig. 8J, K, M, O) co-stained for the oligodendrocyte lineage marker Olig2.
Quantitative analyses (Fig. 9) supported our observations; nearly 90% of paternal Ube3a-
stained glia in both the grey and white matter proved to be Olig2 co-positive (Fig. 9A-G).
Most Ube3a/Olig2 co-positive glia also stained for adenomatous polyposis coli (APC). A
subset of these cells, mostly located in or near the white matter, stained very intensely for
APC, thus revealing them to be mature, myelinating oligodendrocytes (Figs. 8D, F, H, I and
J, L, N, O; 9A, D, G) (Bhat et al., 1996). We observed similar patterns of Olig2/APC co-
localization with maternal (Fig. 10B, E-J) and paternal (Fig. 10C, K-P) Ube3a-YFP,
although maternal Ube3a-YFP-stained glia were more difficult to distinguish against a
backdrop of stained axons. We never observed glial Ube3a-YFP staining in negative control
brain sections from Ube3am+/p+ mice (Fig. 10D). Collectively, these data suggested that glia
of the Olig2-expressing lineage, including myelinating oligodendrocytes, biallelically
express Ube3a during gliogenesis.
Glial Ube3a expression becomes increasingly restricted to mature
oligodendrocytes—A majority of astrocytes express Olig2 during peak gliogenesis (Cai
et al., 2007), indicating that Olig2 expression is not exclusive to the oligodendrocyte lineage
until later in development. To determine if early postnatal populations of paternal Ube3a-
expressing glia comprise astrocytes in addition to oligodendrocytes, we co-stained for the
astrocyte marker glial fibrillary acid protein (GFAP). A subset of paternal Ube3a-stained
glia co-stained for GFAP in both the neocortical (Fig. 11A-D) and hippocampal (Fig. 11E-
H) grey matter of P7 Ube3am–/p+ mice. Paternal Ube3a-stained glia also co-stained for
GFAP in the hippocampi of P28 mice (Fig. 11I-L). This suggested that subpopulations of
astrocytes express Ube3a throughout postnatal development.
By P28, astrocytes in the neocortical grey matter no longer express GFAP. However, they
continue to express low levels of APC and are Olig2-negative. We determined that
astrocytes defined by this staining profile constitute approximately 30% and 20% of all
paternal Ube3a-expressing glia in the neocortical grey matter (Fig. 9H-K) and white matter
(Fig. 9H, N), respectively. By contrast, maternal (Fig. 12B, E, F, H, J) and paternal (Fig.
12C, K, L, N, P) Ube3a/Olig2 co-staining was much more prevalent. Over 60% of paternal
Ube3a-stained glia in the grey matter (Fig. 9H, I, M, K) and nearly 80% of paternal Ube3a-
stained glia in the white matter (Fig. 9H, N) also stained for Olig2, which is a dedicated
oligodendrocyte marker by P28. Many maternal (Fig. 12E, G, I, J) and paternal (Fig. 12K,
M, O, P) Ube3a-stained oligodendrocytes proved to be mature, myelinating cells as
evidenced by intense APC co-staining. In fact, mature oligodendroctyes accounted for
almost 40% of all paternal Ube3a-stained glia in the grey matter (Fig. 9H, I, L, M, K) and
over 50% of such cells in the white matter (Fig. 9H, N). This was a marked proportional
increase from what we observed at P7 (Fig. 9D, G), indicating that Ube3a expression in glia
becomes increasingly restricted to mature oligodendrocytes over the first postnatal month.
Finally, we observed extensive Olig2/APC co-localization with both maternal (Fig. 13B, E-
J) and paternal (Fig. 13C, K-P) Ube3a-YFP at this later postnatal period. From these
observations we drew two main conclusions. First, astrocytes and oligodendrocytes are the
two major glial cell types that biallelically express Ube3a. Second, presumptive myelinating
oligodendrocytes emerge as the predominant Ube3a-expressing glial cell type during
postnatal development.
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We extensively mapped allele-specific Ube3a protein expression in the developing postnatal
brain. Our development of an immunofluorescent Ube3a staining protocol sensitive enough
to detect low levels of paternal Ube3a protein in Ube3am–/p+ mice was critical to the success
of this venture. Nevertheless, we were conscientious of the possibility that transcription
from the paternal Ube3a locus or stability of the resultant transcript or protein might be
abnormal in an AS-like developmental context. Therefore, we undertook a complementary
approach, staining for paternal Ube3a-YFP in Ube3am+/pYFP mice that express an intact
copy of maternal Ube3a. We observed a high degree of correspondence between paternal
Ube3a and paternal Ube3a-YFP staining patterns, which bolstered our confidence in their
veracity. Reciprocal Ube3a-YFP staining experiments in Ube3amYFP/p+ mice, performed in
parallel, allowed us to isolate maternal Ube3a contributions to the Ube3a protein pool. A
limitation of using such parallel approaches is that paternal and maternal Ube3a cannot be
distinguished from one another within the same animal. Consequently, we were unable to
address the possibility of more subtle maternal expression bias within brain cells that
biallelically express Ube3a (e.g., neural progenitors of the SGZ and oligodendrocytes) as has
been seen in peripheral tissues (Herzing et al., 2002; Gustin et al., 2010). We keep these
experimental advantages and limitations in mind as we discuss our findings in broader
contexts.
Developmental changes in Ube3a subcellular localization: causes and consequences
We observed a striking cytoplasmic to nuclear shift in Ube3a subcellular localization in
neurons over postnatal development. Potential causes of this shift may include changes in
the expression of Ube3a protein isoforms and/or interacting proteins that affect Ube3a
trafficking. Differential amino-terminal splicing produces 3 isoforms of human UBE3A
(Yamamoto et al., 1997). Proteomic analysis of UBE3A-interacting proteins in heterologous
systems has revealed a limited number of isoform-specific UBE3A protein partners that
could reflect (or perhaps even dictate) unique patterns of subcellular distribution (Martinez-
Noel et al., 2012). Whether such interactions occur in neurons, change over development, or
affect UBE3A localization is not yet known.
Mice also express three known Ube3a isoforms. Isoform II encodes the entire Ube3a open
reading frame, whereas I and III encode isoforms lacking the first 21 amino-terminal amino
acids. Isoform I may also lack 87 carboxy-terminal amino acids that are critical for E3 ligase
function (Greer et al., 2010; Miao et al., 2013). Miao et al. (2013) overexpressed each of
these isoforms individually in neurons lacking endogenous Ube3a expression due to short
hairpin RNA knock-down. In their study, overexpressed isoforms I and II localized
preferentially to the cytoplasm, while overexpressed isoform III localized to the nucleus.
Interestingly, only isoform II overexpression resulted in a statistically significant rescue of
dendritic morphogenesis in these experiments, suggesting that cytoplasmically localized
Ube3a plays a preferential role in this process. Curiously, Miao et al. (2013) also found that
isoform III mRNA was progressively down-regulated over development. This finding is
seemingly at odds with our observation that neurons preferentially localize Ube3a to the
nucleus as they mature. The antibody that we used to immunofluorescently stain for Ube3a
was generated using an immunogen sequence shared by all three isoforms (Table 1).
Isoform-specific Ube3a antibodies and Ube3a knock-in mice, when available, should help to
clarify putative relationships between Ube3a isoform expression, protein localization, and
function.
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Paternal Ube3a expression in immature versus mature neurons
Relaxed paternal Ube3a imprinting in developing neurons has been invoked as a hypothesis
to explain the absence (Sato and Stryker, 2010) or differential expression (Heck et al., 2008)
of certain phenotypes in Ube3am–/p+ and Ube3am–/p– mice. However, due in part to
insufficient paternal Ube3a expression mapping, this hypothesis has lacked much empirical
basis. Here, we produced the first paternal Ube3a expression map of notable spatiotemporal
resolution. As a result, we found that paternal Ube3a expression is a defining feature of
immature neurons in the postnatal brain, while more mature neurons expressing high levels
of NeuN were devoid of paternal Ube3a expression. These findings support the hypothesis
that paternal Ube3a silencing is established during the process of neuronal maturation.
Epigenetic silencing of paternal Ube3a in neurons requires expression in cis of a Ube3a
antisense sequence (Ube3a-ATS) located at the 3’ end of a large noncoding RNA transcript
(lncRNA) (Huang et al., 2012; Meng et al., 2012). Ube3a-ATS is hypothesized to interfere
with the transcription of paternal Ube3a from the opposite DNA strand (Lalande and
Calciano, 2007; Leung et al., 2011). The lncRNA is transcribed from a paternal promoter,
which becomes highly active due to allele-specific hypomethylation of a bipartite imprinting
center that controls the expression of imprinted genes within the region (Sutcliffe et al.,
1994). In immature neurons, transcription of the lncRNA all the way through the Ube3a-
ATS region may be inhibited by chromatin condensation. However, as a neuron matures,
chromatin downstream of the Snrpn locus is hypothesized to relax, enabling transcription of
the lncRNA completely through the Ube3a-ATS region and, in turn, silencing of paternal
Ube3a (Leung et al., 2011). Indeed, in the adult mouse brain there are paternal Ube3a-ATS
transcripts that correspond to Ube3a promoter regions upstream of Ube3a transcription start
site, encouraging speculation that they are required to fully silence paternal Ube3a (Numata
et al., 2011), Elegant fluorescence in situ hybridization experiments targeting the Snrpn-
Ube3a genomic region have revealed that decondensaton of this paternal genomic region
occurs in neocortical neurons sometime during the first two postnatal weeks (Leung et al.,
2009). This finding is generally consistent with our observation that neocortical neurons
cease to express detectable levels of paternal Ube3a by P7.
Consideration of allele-specific Ube3a expression in the context of AS pathogenesis
The quest to understand the molecular and cellular bases of AS naturally began with a focus
on neurons; maternal UBE3A mutations are sufficient to cause AS (Kishino et al., 1997;
Matsuura et al., 1997; Sutcliffe et al., 1997), and neurons are the only cell type known to
have an extreme maternal UBE3A expression bias. We now know, nearly 15 years after
publication of the first Ube3am–/p+ mouse models (Jiang et al., 1998; Miura et al., 2002),
that maternal Ube3a deletion adversely affects the function of diverse neuronal populations
(Kaphzan et al., 2011; Mabb et al., 2011; Riday et al., 2012; Wallace et al., 2012; Egawa et
al., 2012; Condon et al., 2013; Miao et al., 2013). This is generally consistent with the broad
distribution of maternal Ube3a in the adult brain (Gustin et al., 2010), but valuable insight is
lost whenever phenotypes that emerge developmentally are interpreted in the context of
adult expression patterns. Neurons within the thalamus, thalamic reticular nucleus, and
cortex of adult mice all express maternal Ube3a, which has led to the hypothesis that sleep
disturbances, generalized seizures, and electroencephalographic abnormalities in both
Ube3am–/p+ mice (Jiang et al., 1998; Colas et al., 2005) and AS patients (Miano et al., 2004;
Pelc et al., 2008; Conant et al., 2009; Thibert et al., 2013) are due to thalamocortical circuit
disruption (Gustin et al., 2010). This hypothesis did not initially account for subplate
neurons, which are key mediators of thalamocortical circuit development (Kanold and
Luhmann, 2010), likely because they only express maternal Ube3a saliently during the early
postnatal period.
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Paternal Ube3a silencing renders neurons especially vulnerable to maternal Ube3a mutation.
Whether maternal Ube3a protein loss leads to haploinsufficiency in cell populations that
biallelically express Ube3a is an open question. We discovered that biallelic Ube3a
expression in the postnatal brain is largely restricted to two distinct cell populations of
particular interest to AS pathogenesis: postnatal neural stem cells and oligodendrocytes.
Ube3a haploinsufficiency in postnatal neural stem cells of the hippocampal SGZ could
possibly affect cognition (Sahay et al., 2011) and mood (Santarelli et al., 2003) – both of
which are altered in individuals with AS (Williams et al., 2006; Thibert et al., 2013).
Although functional roles for maternal Ube3a in SGZ neural stem cells remain to be fully
elucidated, one study in Ube3am–/p+ mice suggests that neurogenesis per se is not affected
(Mardirossian et al., 2009). Rather, maternal Ube3a deficiency moderately limits the
potential for postmitotic SGZ-born neural precursors to mature into NeuN-positive neurons
(Mardirossian et al., 2009). Because paternal Ube3a appears to become silenced during
neuronal maturation, maternal and paternal Ube3a may not be functionally equivalent with
regard to this postmitotic phenotypic outcome. Embryonic neural stem cells of the dorsal
pallium are also likely to biallelically express Ube3a protein (Yamasaki, 2003), but, similar
to SGZ stem cells, may not require maternal Ube3a for neurogenesis as neocortical
lamination and size appear to be normal in early postnatal Ube3am–/p+ mice (M.C. Judson
and B.D. Philpot, unpublished observations).
White matter abnormalities that have been described in AS patients (Harting et al., 2009;
Peters et al., 2011; Tiwari et al., 2012) could potentially be caused by Ube3a
haploinsufficiency in oligodendrocytes. White matter abnormalities in AS are widespread,
consistent with our observation that Olig2-expressing cells throughout the brain express
Ube3a. While the nature of these white matter abnormalities is not yet clear, they may be
due in part to a developmental delay in myelination (Harting et al., 2009; Castro-Gago et al.,
2010). Interestingly, we observed that mature, presumably myelinating, oligodendrocytes
emerge as the predominant Ube3a-expressing glial cell type during the first postnatal month,
coincident with the active myelination of major forebrain axon tracts (Vincze et al., 2008).
However, it is not yet known if maternal Ube3a protein loss in any way compromises the
myelinating capacity of oligodendrocytes. These and other potential cell type-specific
consequences of maternal Ube3a loss will ultimately have to be parsed with the aid of
conditional Ube3a knock-out mouse models. We expect that the knowledge gained in this
study will help to focus experiments in these forthcoming model systems.
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Profiling Ube3a expression in the postnatal brain using an established immunostaining
protocol. A and B: DAB immunostaining for Ube3a (as per Gustin et al., 2010) in coronal
brain sections from wild-type (A, Ube3am+/p+) and AS (B, Ube3am–/p+) mice across
postnatal development. Lowmagnification reveals broadly distributed Ube3a staining in the
brain at all ages, which is grossly absent in Ube3am–/p+ mice (B). C-G: In Ube3am+/p+
mice, intermediate-magnification (corresponding to boxed regions in panel A) reveals
discrete patterns of Ube3a staining in the deepest neocortical layers (arrows, panels C, D)
and in patches of striatal cells (double arrows, panels C, D) from P0-P7. Ube3a staining
within the neocortex and striatum becomes more evenly distributed by P14 (E). This
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staining pattern persists into adolescence (F) and throughout adulthood (G). H-L:
Intermediate-magnification of boxed regions corresponding to panel B demonstrate lack of
specific staining patterns in Ube3am–/p+ mice. M-Q: Highmagnification (boxed regions,
panels C-G), provides greater resolution of Ube3a staining patterns in deep neocortical
layers (arrows, panels M, N) and in striatal patches (double arrows, panels M, N), which
become less salient over development (O-Q). R-V: High-magnification corresponding to
boxed regions in H-L. No specific staining is detected in Ube3am–/p+ images, confirming
that paternal Ube3a immunoreactivity is not reliably detected in the brain at any postnatal
age using this protocol. Ctx, neocortex; Str, striatum; wm, white matter. Scale bar: 2 mm for
A and B; 650 μm for C-L; 170 μm for M-V.
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Improved immunofluorescent detection of Ube3a in the postnatal brain. A-C:
Immunofluorescent staining for Ube3a in coronal sections from wild-type (Ube3am+/p+)
mice at P0 (A), P7 (B), and P28 (C). Gross patterns of staining during the first postnatal
week are nearly identical to those observed with DAB staining, with notable Ube3a
immunoreactivity in deep laminae of the neocortex (arrows, A, B) as well as in patches of
striatal cells (double arrow, A); staining is more uniformly distributed at P28 (C). D-F:
Immunofluorescent staining for paternal Ube3a in matched brain sections from AS mouse
(Ube3am–/p+) littermates. Low levels of paternal Ube3a expression are consistently
observed during postnatal development in specific structures and cell types throughout the
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brain, especially in the superficial neocortex at P0 (D). G-I: Gross immnofluorescent
staining for Ube3a is not observed in negative control sections from double-knockout
(Ube3am–/p–) mice. J-L: High-magnification of the boxed regions in D-F reveals paternal
Ube3a staining in presumptive glia (arrowheads). M-O: No specific staining is apparent in
corresponding high-magnification images from Ube3am–/p– mice. Ctx, neocortex; Str,
striatum. Scale bar: 2 mm for A-I; 120 μm for J-O.
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Ube3a expression is salient in the striosomes and subplate during early postnatal
development in wild-type (Ube3am+/p+) mice. A-H: Images of Ube3a and DARPP-32
immunostaining in P0 (A-D) and P7 (EH) brains. Increased magnification shows that salient
Ube3a staining in the P0 striatum is specific to DARPP-32-positive striosomes (arrows, B-
D). Striosomal Ube3a staining is less salient by P7 (arrows, FH). I-P: Images of Ube3a and
Cplx3 immunoreactivity in the P0 (I-L) and P7 (M-P) brains. In the perinatal (J-L) and early
postnatal (N-P) neocortex, Cplx3-positive subplate neurons exhibit intense Ube3a staining
with a predominantly nuclear localization. Ctx, neocortex; wm, white matter. Scale bar: 435
μm for A, E, I, and M; 70 μm for B-D, F-H, J-L, and N-P.
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Developmental changes in Ube3a expression reflect laminar gradients of neocortical
maturation. A-C: Low-magnification images of Ube3a immunostaining in the developing
neocortex of wildtype (Ube3am+/p+) mice. At P0, subplate neurons most prominently
exhibit nuclear Ube3a immunoreactivity (A). By P7, neurons with notable nuclear staining
are seen throughout the infragranular layers (B), but are not observed in supragranular layers
until later (C). D-L: Within the superficial cortex, the developmental shift in subcellular
Ube3a localization is apparent in high-magnification images captured using thin (1.2 μm)
optical sectioning. Note the increase in Ube3a staining (D-F) in the nuclear compartment
(labeled with DAPI, G-I and J-L) from P0 to P28. Conversely, Ube3a staining in dendritic
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processes (arrows) progressively declines over the first postnatal month. cp, cortical plate;
sp, subplate. Scale bar: 225 μm for A-C; 25 μm for D-L.
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Immature neurons of the perinatal cortex express paternal Ube3a. A-N: Images of paternal
Ube3a and NeuN immunostaining in the developing neocortex of AS (Ube3am–/p+) mice.
Paternal Ube3a is more prominent at P0 (A) than at P0 (H), when a distinct deep (low) to
superficial (high) gradient of staining is observed. At P0, the paternal Ube3a laminar
gradient opposes the staining gradient for NeuN, a mature neuron marker, as shown in high-
magnification images captured using thin (1.2 μm) optical sectioning (BD). In digitally
zoomed images (E-G), paternal Ube3a staining is apparent in presumptive immature neurons
(double arrows) beyond the superficial extent of NeuN staining and in nearby, weakly
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NeuN-positive neurons (arrows) slightly deeper in the cortical plate. At P7, only
presumptive NeuN-negative glia show paternal Ube3a staining, as shown with high-
magnification (I-K; arrow, L-N). O: Western blotting of total cortical and hippocampal
lysates from P0 and P7 wild-type and AS mouse littermates. Paternal Ube3a is more
abundant in AS lysates at P0 than at P7, corroborating the immunostaining data. cp, cortical
plate; wm, white matter. Scale bar: 210 μm for A and H; 35 μm for B-D and I-K; 20 μm for
E-G and L-N.
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Immature granule cells of the hippocampus and cerebellum express paternal Ube3a. A:
Lowmagnification image of paternal Ube3a immunostaining in the dentate gyrus of P7 AS
(Ube3am–/p+) mice. Note the relatively intense staining in the inner band of neurons
adjacent to the hilus. B-G: Highmagnification images captured using thin (1.2 μm) optical
sectioning show that paternal Ube3a staining in the dentate gyrus (panel B) is inversely
correlated with staining for the mature neuronal marker NeuN (C and D). Paternal Ube3a is
clearly observed in weakly NeuN-positive neurons (arrows) in the inner dentate granule cell
layers, whereas it is seemingly absent from strongly NeuN-positive neurons in outer layers
(double arrows) as shown in corresponding, digitally zoomed images (E-G). H: Low-
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magnification image of paternal Ube3a staining in the P7 cerebellum. Note the staining
enrichment in this relatively immature structure. I-N: High-magnification shows enriched
paternal Ube3a staining deep within the external granule cell layer (panel I), localized to
immature neurons that are weakly NeuN-positive (J and K). In digitally zoomed images (L-
N), paternal Ube3a/NeuN co-positive neurons are shown beginning (arrows) or continuing
(double arrow) their migration past Purkinje cells (asterisks) into the internal granule cell
layer. CA1, Cornu Ammonis area 1; H, hilus; IC, inferior colliculus; igl, internal granule
layer; ml, molecular layer; egl, external granule layer. Scale bar: 105 μm for A; 275 μm for
H; 40 μm for B-D and I-K; 19 μm for E-G and L-N.
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Postnatal hippocampal stem cells biallelically express Ube3a. A-C: Low-magnification
images of Ube3a staining in the dentate gyrus of P28 wild-type (A, Ube3am+/p+), AS (B,
Ube3am–/p+), and doubleknockout (C, Ube3am–/p–) mice. Paternal Ube3a staining is
conspicuous within the inner granule cell layer (B) but absent in Ube3am–/p– mice (C). The
signal gain in C was digitally increased so that low levels of nonspecific staining could be
appreciated. D-I: High-magnification of the boxed region in B, depicting paternal Ube3a,
Nestin, and Ki67 staining. Paternal Ube3a (D) and Nestin (E) colocalize (G). Paternal Ube3a
and Ki67 (F) also colocalize (H). Cells that express all three markers (arrow, I) are readily
detected. J-L: Low-magnification images of Ube3a-YFP staining in the dentate gyrus of P28
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maternal Ube3a-YFP (J, Ube3amYFP/p+), paternal Ube3a-YFP (K, Ube3am+/pYFP), and
wild-type (L, Ube3am+/p+) mice. Maternal (J) and paternal (K) Ube3a-YFP staining in the
inner granule cell layer is clearly evident, whereas there is no Ube3a-YFP staining in wild-
type mice (L). M-R: High-magnification of the boxed region in J, depicting maternal
Ube3a-YFP, Nestin, and Ki67 staining. S-X: High-magnification of the boxed region in K,
depicting paternal Ube3a-YFP, Nestin, and Ki67 staining. Maternal (arrow, P-R) and
paternal (arrow, V-X) Ube3a-YFPexpressing cells are found to co-express Nestin and Ki67,
indicating that Ube3a is biallelically expressed by proliferating stem cells in the postnatal
dentate gyrus. CA1, Cornu Ammonis area 1; DG, dentate
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Olig2-expressing glia express paternal Ube3a during gliogenesis. A: DAPI-stained coronal
section from a P7 wild-type mouse. The shaded box indicates the region of interest and the
color key indicates the identity of immunostaining targets. B and C: Low-magnification
images of Ube3a immunostaining in wildtype (B, Ube3am+/p+) and AS (C, Ube3am–/p+)
mice in the region of interest. The paternal Ube3a staining that remains in AS mice is
uniformly distributed in small cells reminiscent of glia (C). D-I: Highmagnification of the
boxed region in B, depicting Ube3a, Olig2, and APC staining in the subcortical white
matter. Against a backdrop of Ube3a-stained axons, small Ube3a-stained glia are seen (D),
nearly all of which are co-stained with Olig2 (E and G). A subset of these glia is heavily co-
stained with APC (arrows, F, H, and I). J-O: High-magnification of the boxed region in C,
depicting paternal Ube3a, Olig2, and APC staining in the subcortical white matter. Paternal
Ube3a-stained glia are particularly salient as surrounding axonal staining is lost. Nearly all
glia co-express Olig2 (K and M) but only a subset strongly co-express APC (arrows, L, N,
and O). CA1, Cornu Ammonis area 1; wm, white matter. Scale bar: 275 μm for B and C; 60
μm for D-O.
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Quantification of paternal Ube3a co-localization with glial markers. A and H: Images of P7
(A) and P28 (H) Ube3am–/p+ somatosensory cortex stained for paternal Ube3a and the glial
markers Olig2 and APC. The boxed regions indicate the areas sampled for co-localization
analysis. Dashed lines indicate white matter boundaries. B, C, E, and F and I, J, L, and M:
Paternal Ube3a co-localization with glial markers in digitally zoomed images of P7 (B, C, E,
and F) and P28 (I, J, L, and M) somatosensory grey matter. Arrows indicate Ube3a co-
localization with Olig2 in the absence of APC; double arrows indicate co-localization of
Ube3a and Olig2 with weak APC staining (APC Lo); arrowheads indicate colocalization of
Ube3a and Olig2 with APC staining that is still visible after thresholding (APC Hi).
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Thresholding for APC Hi helped to select for the intense APC labeling characteristic of
mature oligodendrocytes. D, G, K, and N: Proportionality of distinct paternal Ube3a-
expressing glial subpopulations in the grey matter (D and K) and white matter (G and N) of
somatosensory cortex at P7 (D and G) and P28 (K and N). Values represent the mean
percentage of total paternal Ube3a-stained cells that co-stained with the indicated
combination of immunofluorescent markers. O: Pie chart color key. N = 4 animals per
developmental time point. Optical section thickness = 1.4 μm. Scale bar: 280 μm for A and
H; 60 μm for B, C, E, and F and I, J, L, and M.
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Olig2-positive glia biallelically express Ube3a-YFP during gliogenesis. A: DAPI-stained
coronal section from a P7 wild-type mouse. The shaded box indicates the region of interest
and the color key indicates the identity of immunostaining targets. B-D: Low-magnification
images of Ube3a-YFP immunostaining in maternal Ube3a-YFP (B, Ube3amYFP/p+),
paternal Ube3a-YFP (C, Ube3am+/pYFP), and wildtype (D, Ube3am+/p+) mice. Relative
to maternal Ube3a-YFP staining (B), paternal Ube3a-YFP staining (C) is sparse and evenly
distributed in small cells. No specific YFP staining is observed in wild-type mice (D). E-J:
High-magnification of the boxed region in B, depicting maternal Ube3a-YFP, Olig2, and
APC staining in the subcortical white matter. Stained glial cells are difficult to notice amid
axons that are also maternal Ube3a-YFP-positive (E). Nearly all maternal Ube3a-YFP-
stained glia are Olig2-stained (F and H) and a minor subset also co-stain with APC (arrows,
G, I, and J). K-P: High-magnification of the boxed region in C, depicting paternal Ube3a-
YFP, Olig2, and APC staining in the subcortical white matter. There is no apparent paternal
Ube3a-YFP staining in axons, so stained glia are readily detected (K). Most paternal Ube3a-
YFP stained glia also express Olig2 (L and N) and a few also express APC (arrows, M, O,
and P). CA1, Cornu Ammonis area 1; wm, white matter. Scale bar: 340 μm for B-D; 60 μm
for E-P.
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Co-expression of paternal Ube3a and GFAP. A-D: Paternal Ube3a (B), NeuN (C), and
GFAP (D) staining in the P7 Ube3am–/p+ somatosensory cortex. E-H: Paternal Ube3a (F),
NeuN (G), and GFAP (H) staining in the P7 Ube3am–/p+ hippocampus. I-L: Paternal
Ube3a (J), NeuN (K), and GFAP (L) staining in the P28 Ube3am–/p+ hippocampus.
Arrowheads indicate representative glia that are clearly co-stained with both paternal Ube3a
and GFAP. pyr, pyramidal layer of hippocampus; rad, stratum radiatum of hippocampus.
Optical section thickness = 1.4 μm. Scale bar: 45 μm for all panels.
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Mature oligodendrocytes express paternal Ube3a. A: DAPI-stained coronal section from a
P28 wild-type mouse. The shaded box indicates the region of interest and the color key
indicates the identity of immunostaining targets. B-D: Low-magnification images of Ube3a
immunostaining in wild-type (B, Ube3am+/p+), AS (C, Ube3am–/p+), and double-
knockout (D, Ube3am–/p–) mice in the region of interest. The majority of staining observed
in wild-type mice (B) is lost in AS mice (C), but glial profiles that are concentrated in the
white matter persist. These patterns are absent in double-knockout mice (D). E-J: High-
magnification of the boxed region in B, depicting Ube3a, Olig2, and APC staining in the
callosum. Glial cells and surrounding axons are stained for Ube3a (E). Most Ube3a-stained
glia in this myelinated tract costain for Olig2 (F and H) and APC (arrows, G, I, and J). K-P:
High-magnification of the boxed region in C, depicting paternal Ube3a, Olig2, and APC
staining in the callosum. Paternal Ube3a staining in glia is apparent in the absence of axonal
maternal Ube3a staining (K). Paternal Ube3a-stained glia in the callosum are frequently co-
stained with both Olig2 (L and N) and the mature oligodendrocyte marker APC (arrows, M,
O, and P). cc, corpus callosum; dhc, dorsal hippocampal commissure. Scale bar: 340 μm for
B-D; 60 μm for E-P.
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Mature oligodendrocytes biallelically express Ube3a-YFP. A: DAPI-stained coronal section
from a P28 wild-type mouse. The shaded box indicates the region of interest and the color
key indicates the identity of immunostaining targets. B-D: Low-magnification images of
Ube3a-YFP immunostaining in maternal Ube3a-YFP (B, Ube3amYFP/p+), paternal Ube3a-
YFP (C, Ube3am+/pYFP), and wild-type (D, Ube3am+/p+) mice. Maternal Ube3a-YFP
staining is intense and distributed broadly in neurons (B), whereas paternal Ube3a-YFP
staining is concentrated in callosal glia (C). These patterns are absent in wild-type mice (D).
EJ: High-magnification of the boxed region in B, depicting maternal Ube3a-YFP, Olig2,
and APC staining in the callosum. Maternal Ube3a-YFP is present in glia (E) which are
largely Olig2 (F and H) and APC co-positive (arrows, G, I, and J). K-P: High-magnification
of the boxed region in C, depicting paternal Ube3a-YFP, Olig2, and APC staining in the
callosum. Paternal Ube3a-YFP staining is present in glia but not axons in the callosum (K).
Paternal Ube3a-YFP-stained glia are nearly always co-stained with Olig2 (L and N) and
frequently co-stained with the mature oligodendrocyte marker APC (arrows, M, O, and P).
cc, corpus callosum; dhc, dorsal hippocampal commissure. Scale bar: 340 μm for B-D; 60
μm for E-P.
JUDSON et al. Page 37

























JUDSON et al. Page 38
Table of Primary Antibodies used
Antigen Immunogen Manufacturer Dilution used
APC recombinant peptide corresponding to a.a.1-226 of
APC
Millipore (Billerica, MA), mouse
monoclonal, clone CC-1, OP80
1:500
Cplx3 recombinant full-length mouse Cplx3 Synaptic Systems (Goettingen, DE),
rabbit polyclonal, 122-302
1:1,000
DARPP-32 peptide corresponding to a.a. 20-40 of mouse
DARPP-32
Millipore, rabbit polyclonal, AB10518 1:250
GAPDH GAPDH purified from rabbit muscle Millipore, mouse monoclonal, clone
6C5, MAB374
1:5,000
GFAP GFAP purified from cow spinal cord Dako (Glostrup, DK), rabbit
polyclonal, Z0334
1:1,000
GFP purified recombinant GFP Aves Labs (Tigard, OR), chicken
polyclonal, GFP-1020
1:2,500
Ki67 Prokaryotic recombinant fusion protein
corresponding to a 1088 bp Ki67 motif-containing
cDNA fragment
Leica (Wetzlar, DE), rabbit polyclonal,
Ki67p
1:2,000
Olig2 recombinant mouse Olig2 Millipore, rabbit polyclonal, AB9610 1:500
Nestin Nestin purified from embryonic rat spinal cord Millipore, mouse monoclonal, clone
rat-401, MAB353
1:2,000
NeuN purified nuclei from mouse brain Millipore, mouse monoclonal, clone
A60, MAB377
1:500
Ube3a recombinant full-length human UBE3A Sigma-Aldrich (St. Louis, MO), mouse
monoclonal, clone E6AP-330, E8655
1:200 (chromogenic staining)
Ube3a peptide corresponding to a.a. 315-415 (isoforms 1





Note: a.a., amino acids; bp, base pair; APC, adenomatous polyposis coli; Cplx3, Complexin 3; DARPP-32, Dopamine and cAMP-Regulated
Phosphoprotein-32 kD; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; GFAP, Glial Fibrillary Acid Protein; GFP, Green Fluorescent
Protein; Olig2, Oligodendrocyte transcription factor 2; NeuN, Neuronal Nuclei; Ube3a, Ubiquitin protein ligase e3a.
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